APOE and Alzheimer disease: With the current study accounted for, our team has assessed plasma apoE levels in three different cohorts including non-demented APOEε3/ε4 individuals from the Arizona APOE Study (USA) [37], non-AD subjects and AD patients from Sweden [21], and the current cohort of patients and controls from Norway.